Omeros (OMER) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,456.00 |
| Sep 30, 2021 | 2,056.00 |
| Jun 30, 2021 | 3,220.00 |
| Mar 31, 2021 | 3,294.00 |
| Dec 31, 2020 | 7,635.00 |
| Sep 30, 2020 | 31,578.00 |
| Jun 30, 2020 | 24,377.00 |
| Mar 31, 2020 | 446,501.00 |
| Dec 31, 2019 | 865,719.00 |
| Sep 30, 2019 | 742,888.00 |
| Jun 30, 2019 | 3.39 Mn |
| Mar 31, 2019 | 1.11 Mn |
| Dec 31, 2018 | 10,238.00 |
| Sep 30, 2018 | 485,400.00 |
| Jun 30, 2018 | 483,006.00 |
| Mar 31, 2018 | 10,417.00 |
| Dec 31, 2017 | 80,297.00 |
| Sep 30, 2017 | 47,681.00 |
| Jun 30, 2017 | 53,646.00 |
| Mar 31, 2017 | 26,858.00 |
| Dec 31, 2016 | 56,305.00 |
| Sep 30, 2016 | 31,706.00 |
| Jun 30, 2016 | 46,362.00 |
| Mar 31, 2016 | 46,651.00 |
| Dec 31, 2015 | -92,305.00 |
| Sep 30, 2015 | 193,282.00 |